NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

預防醫療保健技術及服務的全球市場:目前分析與預測(2020年∼2027年)

Global Preventive Healthcare Technologies and Services Market: Current Analysis and Forecast (2020-2027)

出版商 UnivDatos Market Insights Pvt Ltd 商品編碼 977823
出版日期 內容資訊 英文 204 Pages
商品交期: 最快1-2個工作天內
價格
預防醫療保健技術及服務的全球市場:目前分析與預測(2020年∼2027年) Global Preventive Healthcare Technologies and Services Market: Current Analysis and Forecast (2020-2027)
出版日期: 2020年12月22日內容資訊: 英文 204 Pages
簡介

全球預防醫療保健技術及服務的市場規模,2019年是2,141億美金。該市場,預計從2021年到2027年之間以10.5%的年複合成長率大幅度擴大。由於慢性疾病相關患者的增加和在醫療保健領域的技術的進步的採用,預計推動該市場成長。

本報告提供全球預防醫療保健技術與服務市場的相關調查,市場機會和課題,成長及阻礙因素,COVID-19大流行的影響,各類型、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 市場簡介

  • 市場定義
  • 調查的目的
  • 限制
  • 相關利益者
  • 報告所使用的貨幣
  • 市場調查範圍

第2章 調查手法或前提條件

  • 調查手法
    • 市場調查的主要目的

第3章 產業的成果

第4章 摘要整理

第5章 市場概要

  • 簡介
  • 市場動態
    • 市場趨勢和成長要素
    • 市場課題
    • 市場機會

第6章 法律及法律規範

  • 整體概述

第7章 需求與供給方面分析

  • 需求面分析
  • 供給方面分析
    • 主要產品的銷售
    • 主要商務聯盟
    • 主要的合併和收購
    • 主要商務的擴大及投資
    • 主要的Start-Ups

第8章 價值鏈分析

  • 價值鏈分析

第9章 市場分析:各類型

  • 整體概述
    • 慢性疾病管理技術
    • 早期發現及篩檢技術
    • 疫苗
    • 為了減少錯誤的先進技術

第10章 市場分析:各地區

  • 整體概述
  • 北美市場
    • 美國
    • 加拿大
    • 其他
  • 歐洲市場
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 其他
  • 亞太地區市場
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他

第11章 競爭模式

  • 波特的五力分析
  • 競爭情形
    • 主要企業的市場佔有率(2019)

第12章 主要企業的簡介

  • Medtronic PLC
  • Alere
  • GlaxoSmithKline
  • McKesson Corporation
  • Merck & Co.
  • Myriad Genetics
  • Omron Healthcare
  • Quest Diagnostics
  • Sanofi
  • Tivity Health
目錄
Product Code: UMHE20193

The surging prevalence of lifestyle diseases such as cardiovascular disease, cancer, diabetes, and obesity is the root cause of the escalating adoption of technology in the healthcare sector. With the advent of new technologies such as AI, Big data, and ML, the healthcare industry across the globe is moving towards a rapid transformation. Moreover, the awareness about preventive measures such as screening & monitoring devices, vaccines, and smart devices to reduce medical errors owing to the rising geriatric population who are more prone to chronic diseases. As per a report by United Nations, "There were 703 million persons aged 65 years or over in the world in 2019. The number of older persons is projected to double to 1.5 billion in 2050". Therefore, the emerging need for identification and diagnosis of disease at the early stage the demand for preventive healthcare technologies and services is on the rise owing to the growing awareness among end-users to keep track of their health progress on a real-time basis. Some of the tech trends that are reshaping preventive healthcare across the globe are portable Medical devices for home monitoring, Healthcare wearables, Electronic Health Records (EHRs), access to quality health delivery, payment control, etc.

Furthermore, the governments across countries are progressively promoting the cause of preventive healthcare as the first step in a quality healthcare infrastructure. Therefore, the government of the countries such as the US, China, India, Australia, etc. has launched several initiatives for spreading awareness about preventive health measures among end-users.

Moreover, the abrupt rise in healthcare spending across the globe is one of the key contributing factors driving market growth. In the past few years, a rise in investments was witnessed. In 2018 and 2019 there was an increase in the investment into well-being and care delivery innovators. Moreover, the solution providers or the innovators are adopting technologies such as AI, machine learning (ML), and the Internet of Things (IoT) for the better operations and results of their product or services.

Based on the type, the preventive healthcare technologies and services market is bifurcated into Early Detection and Screening Technologies, Vaccines, Chronic Disease Management Technologies, and Advanced Technologies to Reduce Errors. The Early Detection and Screening Technologies sub-segment is further subdivided into Automated Screening, Personalized Medicine, and Other Advanced Screening Technologies. Moreover, the Vaccines segment is divided into Infectious Diseases, Autism, Allergy, Cancer, Other Vaccines. Furthermore, the Chronic Disease Management Technologies segment is further bifurcated to Blood Pressure Monitors, Asthma Monitors, Cardiovascular Monitors, Glucose Monitors. Also, Advanced Technologies to Reduce Errors subsegment is segregated to electronic Prescribing, Clinical Decision Support Systems, Smart Infusion Pumps, Computerized Provider Order Entry Systems, Smart Packaging, and Automated Prescription Formulation and Dispensing.

Preventive healthcare technologies help the end-users in early diagnostics of any disease that helps in improving health in the Long-Term, Avoid High Medical Expenses. Early Detection and Screening Technologies Market generated revenue of US$ 93.9 billion in 2019 and is expected to grow at the highest CAGR of 11% during the forecast period to reach a market valuation of US$ 225.2 billion by 2027.

For a better understanding of the market penetration of preventive healthcare technologies and services, the market is analyzed based on its worldwide presence in the region such as North America (US, Canada, Rest of North America), Europe (Germany, UK, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), and Rest of World. North America constitutes a major market for preventive healthcare technologies and services industry. Some of the major players operating in the market include Medtronic, Alere, GlaxoSmithKline, McKesson Corporation, Merck & Co, Myriad Genetics, Omron Healthcare, Quest Diagnostics, Sanofi, and Tivity Health.

The global preventive healthcare technologies and services market was valued at US$ 214.1 billion in 2019 and is projected to expand significantly with the CAGR of 10.5% from 2021-2027. The global preventive healthcare technologies and services market is expected to witness a boost, owing to the escalating number of chronic disease-related patients and the adoption of advancements in technologies in the healthcare sector.

TABLE OF CONTENTS

1. MARKET INTRODUCTION

  • 1.1 Market Definition
  • 1.2 Objective of the Study
  • 1.3 Limitation
  • 1.4 Stakeholders
  • 1.5 Currency used in the Report
  • 1.6 Scope of the Global Preventive Healthcare Technologies and Services Market Study

2. RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1 Research Methodology for the Preventive Healthcare Technologies and Services Market Study
    • 2.1.1 Main objective of the Preventive Healthcare Technologies and Services Market Study

3. INDUSTRY PERFORMANCE

4. EXECUTIVE SUMMARY

5. MARKET OVERVIEW

  • 5.1 Introduction
  • 5.2 Market Dynamics
    • 5.2.1 Market Trend & Drivers
      • 5.2.1.1 Escalating Aging Population and Related Disease
      • 5.2.1.2 Escalating Awareness Programs and Mandates by the Government
      • 5.2.1.3 Easy Availability of Early Detection Capable Diagnostics Devices
    • 5.2.2 Market Challenges
      • 5.2.2.1 Lack of Understanding about the need for Preventive Healthcare Measures in Rural Areas
      • 5.2.2.2 Lack of Skilled Healthcare Technology Professionals in Developing Nations
    • 5.2.3 Market Opportunities
      • 5.2.3.1 Surging Adoption of Technologies such as AI, ML and IoT in Healthcare
      • 5.2.3.2 Rising Penetration of Communicable Diseases

6. LEGAL & REGULATORY FRAMEWORK

  • 6.1 General Overview

7. DEMAND AND SUPPLY SIDE ANALYSIS

  • 7.1 Demand Side Analysis
  • 7.2 Supply Side Analysis
    • 7.2.1 Top Product Launches
    • 7.2.2 Top Business Partnerships
    • 7.2.3 Top Mergers and Acquisitions
    • 7.2.4 Top Business Expansions and Investment
    • 7.2.5 Top Start-ups under Preventive Healthcare Technologies and Services Sector

8. VALUE CHAIN ANALYSIS

  • 8.1 Value Chain Analysis

9. MARKET INSIGHTS BY TYPE

  • 9.1 General Overview
    • 9.1.1 Chronic Disease Management Technologies
      • 9.1.1.1 Blood Pressure Monitoring
      • 9.1.1.2 Asthma Monitors
      • 9.1.1.3 Cardiovascular Monitors
      • 9.1.1.4 Glucose Monitors
    • 9.1.2 Early Detection and Screening Technologies
      • 9.1.2.1 Personalized Medicine
      • 9.1.2.2 Other Screening Technologies
    • 9.1.3 Vaccines
      • 9.1.3.1 Infectious Diseases
      • 9.1.3.2 Allergy
      • 9.1.3.3 Cancer
      • 9.1.3.4 Other Vaccines
    • 9.1.4 Advanced Technologies to Reduce Error
      • 9.1.4.1 Electronic Prescribing
      • 9.1.4.2 Clinical Decision Support Systems
      • 9.1.4.3 Smart Infusion Pumps
      • 9.1.4.4 Computerized Provider Order Entry Systems Market
      • 9.1.4.5 Smart Packaging and Automated Prescription Formulation and Dispensing

10. MARKET INSIGHTS BY REGION

  • 10.1 General Overview
  • 10.2 North America Preventive Healthcare Technologies and Services Market
    • 10.2.1 United States Preventive Healthcare Technologies and Services Market
    • 10.2.2 Canada Preventive Healthcare Technologies and Services Market
    • 10.2.3 Rest of North America Preventive Healthcare Technologies and Services Market
  • 10.3 Europe Preventive Healthcare Technologies and Services Market
    • 10.3.1 UK Preventive Healthcare Technologies and Services Market
    • 10.3.2 Germany Preventive Healthcare Technologies and Services Market
    • 10.3.3 France Preventive Healthcare Technologies and Services Market
    • 10.3.4 Spain Preventive Healthcare Technologies and Services Market
    • 10.3.5 Italy Preventive Healthcare Technologies and Services Market
    • 10.3.6 Rest of Europe Preventive Healthcare Technologies and Services Market
  • 10.4 Asia-Pacific Preventive Healthcare Technologies and Services Market
    • 10.4.1 Japan Preventive Healthcare Technologies and Services Market
    • 10.4.2 China Preventive Healthcare Technologies and Services Market
    • 10.4.3 India Preventive Healthcare Technologies and Services Market
    • 10.4.4 Rest of Asia Pacific Preventive Healthcare Technologies and Services Market
  • 10.5 Rest of the World Preventive Healthcare Technologies and Services Market

11. COMPETITIVE SCENARIO

  • 11.1 Porter's Five forces analysis
    • 11.1.1 Bargaining power of Supplier
    • 11.1.2 Bargaining power of Buyer
    • 11.1.3 Industry Rivalry
    • 11.1.4 Availability of Substitute
    • 11.1.5 Threat of new Entrants
  • 11.2 Competitive Landscape
    • 11.2.1 Market Share of Key Players in Preventive Healthcare Technologies and Services Market, 2019

12. TOP COMPANY PROFILES

  • 12.1 Medtronic PLC
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Key Product/Services Offerings
    • 12.1.4 Growth Strategy
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Financials
      • 12.1.6.1 Revenue Split
    • 12.1.7 Recent Developments
      • 12.1.7.1 Product Launches
      • 12.1.7.2 Partnerships
      • 12.1.7.3 Merger and Acquisitions
  • 12.2 Alere
  • 12.3 GlaxoSmithKline
  • 12.4 McKesson Corporation
  • 12.5 Merck & Co.
  • 12.6 Myriad Genetics
  • 12.7 Omron Healthcare
  • 12.8 Quest Diagnostics
  • 12.9 Sanofi
  • 12.10 Tivity Health

LIST OF TABLES

  • TABLE 1 Top Product Launches
  • TABLE 2 Top Business Partnerships
  • TABLE 3 Top Mergers and Acquisitions
  • TABLE 4 Top Business Expansions and Investment
  • TABLE 5 Medtronic PLC, Key Facts
  • TABLE 6 Medtronic PLC, Ownership Structure
  • TABLE 7 Products segmentation of Medtronic PLC
  • TABLE 8 Medtronic PLC Growth Strategy
  • TABLE 9 Medtronic PLC, Product Launches
  • TABLE 10 Medtronic PLC, Partnerships
  • TABLE 11 Medtronic PLC, Merger and Acquisitions
  • TABLE 12 Alere, Key Facts
  • TABLE 13 Alere, Ownership Structure
  • TABLE 14 Products segmentation of Alere
  • TABLE 15 Alere, Growth Strategy
  • TABLE 16 Alere, Product Launches
  • TABLE 17 Alere, Partnerships
  • TABLE 18 Alere, Mergers and Acquisitions
  • TABLE 19 Alere, Business Expansions, Investment and Divestitures
  • TABLE 20 GlaxoSmithKline, Key Facts
  • TABLE 21 GlaxoSmithKline, Ownership Structure
  • TABLE 22 Products segmentation of GlaxoSmithKline
  • TABLE 23 GlaxoSmithKline, Growth Strategy
  • TABLE 24 GlaxoSmithKline, Product Launches
  • TABLE 25 GlaxoSmithKline, Partnerships
  • TABLE 26 GlaxoSmithKline, Mergers and Acquisitions
  • TABLE 27 GlaxoSmithKline, Business Expansions, Investment and Divestitures
  • TABLE 28 McKesson Corporation, Key Facts
  • TABLE 29 McKesson Corporation, Ownership Structure
  • TABLE 30 Products segmentation of McKesson Corporation
  • TABLE 31 McKesson Corporation, Growth Strategy
  • TABLE 32 McKesson Corporation, Product Launches
  • TABLE 33 McKesson Corporation, Partnerships
  • TABLE 34 McKesson Corporation, Mergers and Acquisitions
  • TABLE 35 McKesson Corporation, Business Expansions, Investment and Divestitures
  • TABLE 36 Merck & Co., Key Facts
  • TABLE 37 Merck & Co., Ownership Structure
  • TABLE 38 Products segmentation of Merck & Co.
  • TABLE 39 Merck & Co., Growth Strategy
  • TABLE 40 Merck & Co., Product Launches
  • TABLE 41 Merck & Co., Partnerships
  • TABLE 42 Merck & Co., Mergers and Acquisitions
  • TABLE 43 Merck & Co., Business Expansions, Investment and Divestitures
  • TABLE 44 Myriad Genetics, Key Facts
  • TABLE 45 Myriad Genetics, Ownership Structure
  • TABLE 46 Products segmentation of Myriad Genetics
  • TABLE 47 Myriad Genetics, Growth Strategy
  • TABLE 48 Myriad Genetics, Product Launches
  • TABLE 49 Myriad Genetics, Partnerships
  • TABLE 50 Myriad Genetics, Mergers and Acquisitions
  • TABLE 51 Myriad Genetics, Business Expansions, Investment and Divestitures
  • TABLE 52 Omron Healthcare, Key Facts
  • TABLE 53 Omron Healthcare, Ownership Structure
  • TABLE 54 Products segmentation of Omron Healthcare
  • TABLE 55 Omron Healthcare, Growth Strategy
  • TABLE 56 Omron Healthcare, Product Launches
  • TABLE 57 Omron Healthcare, Partnerships
  • TABLE 58 Omron Healthcare, Mergers and Acquisitions
  • TABLE 59 Omron Healthcare, Business Expansions, Investment and Divestitures
  • TABLE 60 Quest Diagnostics, Key Facts
  • TABLE 61 Quest Diagnostics, Ownership Structure
  • TABLE 62 Products segmentation of Quest Diagnostics
  • TABLE 63 Quest Diagnostics, Growth Strategy
  • TABLE 64 Quest Diagnostics, Product Launches
  • TABLE 65 Quest Diagnostics, Partnerships
  • TABLE 66 Quest Diagnostics, Mergers and Acquisitions
  • TABLE 67 Quest Diagnostics, Business Expansions, Investment and Divestitures
  • TABLE 68 Sanofi, Key Facts
  • TABLE 69 Sanofi, Ownership Structure
  • TABLE 70 Products segmentation of Sanofi
  • TABLE 71 Sanofi, Growth Strategy
  • TABLE 72 Sanofi, Product Launches
  • TABLE 73 Sanofi, Partnerships
  • TABLE 74 Sanofi, Mergers and Acquisitions
  • TABLE 75 Sanofi, Business Expansions, Investment and Divestitures
  • TABLE 76 Tivity Health, Key Facts
  • TABLE 77 Tivity Health, Ownership Structure
  • TABLE 78 Products segmentation of Tivity Health
  • TABLE 79 Tivity Health, Growth Strategy
  • TABLE 80 Tivity Health, Product Launches
  • TABLE 81 Tivity Health, Partnerships
  • TABLE 82 Tivity Health, Mergers and Acquisitions
  • TABLE 83 Tivity Health, Business Expansions, Investment and Divestitures

LIST OF FIGURES

  • FIG. 1 Scope of the Global Preventive Healthcare Technologies and Services Market Study
  • FIG. 2 Research Methodology for the Preventive Healthcare Technologies and Services Market Study
  • FIG. 3 Healthcare Spending by Government, By Countries, 2015-2019, US$ per Capita
  • FIG. 4 Investors Involved in VC Deals, By Fund Type, 2011-2019, US$ Billion
  • FIG. 5 Global Preventive Healthcare Technologies and Services Market, 2019-2027 (US$ Billion)
  • FIG. 6 Levels of Preventive Healthcare and the Ultimate Goal
  • FIG. 7 World Population Ageing, 2019 -2050
  • FIG. 8 Worldwide Share of Deaths, by Cause (Percentage)
  • FIG. 9 Prevalence of Chronic Disease, By Region
  • FIG. 10 Value Chain Analysis in Preventive Healthcare Technologies and Services Market
  • FIG. 11 Global Preventive Healthcare Technologies and Services Market Share by Type, 2019 & 2027 (%)
  • FIG. 12 Global Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 13 The Changing Tech Investment Landscape (Rankings Sum)
  • FIG. 14 Global Preventive Healthcare Technologies and Services Market Share, by Chronic Disease Management Technologies, 2019 & 2027 (%)
  • FIG. 15 Global Preventive Healthcare Technologies and Services Market Size by Chronic Disease Management Technologies Type, 2019-2027 (US$ Billion)
  • FIG. 16 Global Chronic Disease Management Technologies Preventive Healthcare and Services Market by Region, 2019-2027 (US$ Billion)
  • FIG. 17 Progression from lifestyle changes to the incidence of Hypertension and Cardiovascular Disease (CVD)
  • FIG. 18 Global Blood Pressure Monitors Market by Region, 2019-2027 (US$ Billion)
  • FIG. 19 Global Asthma Monitors Market by Region, 2019-2027 (US$ Billion)
  • FIG. 20 Global Cardiovascular Monitors Market by Region, 2019-2027 (US$ Billion)
  • FIG. 21 Global Glucose Monitors Market by Region, 2019-2027 (US$ Billion)
  • FIG. 22 Global Preventive Healthcare Technologies AND Services Market Share by Early Detection and Screening Technologies, 2019 & 2027 (%)
  • FIG. 23 Global Preventive Healthcare Technologies AND Services Market Share by Early Detection and Screening Technologies, 2019-2027 (US$ Billion)
  • FIG. 24 Global Personalized Medicine Market by Region, 2019-2027 (US$ Billion)
  • FIG. 25 Global Other Screening Technologies Market by Region, 2019-2027 (US$ Billion)
  • FIG. 26 Global Preventive Healthcare Technologies AND Services Market Share by Vaccines, 2019 & 2027 (%)
  • FIG. 27 Global Preventive Healthcare Technologies AND Services Market Share by Vaccines, 2019-2027 (US$ Billion)
  • FIG. 28 Global Infectious Diseases Market by Region, 2019-2027 (US$ Billion)
  • FIG. 29 Global Allergy Market by Region, 2019-2027 (US$ Billion)
  • FIG. 30 Global Cancer Market by Region, 2019-2027 (US$ Billion)
  • FIG. 31 Global Other Vaccines Market by Region, 2019-2027 (US$ Billion)
  • FIG. 32 Global Preventive Healthcare Technologies and Services Market Share by Advanced Technologies to Reduce Errors, 2019 & 2027 (%)
  • FIG. 33 Global Preventive Healthcare Technologies and Services Market Share by Advanced Technologies to Reduce Errors, 2019-2027 (US$ Billion)
  • FIG. 34 Global Electronic Prescribing Market by Region, 2019-2027 (US$ Billion)
  • FIG. 35 Global Clinical Decision Support Systems Market by Region, 2019-2027 (US$ Billion)
  • FIG. 36 Global Smart Infusion Pumps Market by Region, 2019-2027 (US$ Billion)
  • FIG. 37 Global Computerized Provider Order Entry Systems Market by Region, 2019-2027 (US$ Billion)
  • FIG. 38 Global Smart Packaging and Automated Prescription Formulation and Dispensing Market by Region, 2019-2027 (US$ Billion)
  • FIG. 39 Global Preventive Healthcare Technologies and Services Market Share by Region, 2019 & 2027 (%)
  • FIG. 40 Health Spending (Total % of GDP), 2015-2019
  • FIG. 41 Global Preventive Healthcare Technologies and services Market Size by Region, 2019-2027 (US$ Billion)
  • FIG. 42 North America Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 43 North America Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 44 North America Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 45 North America Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 46 North America Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 47 North America Preventive Healthcare Technologies and Services Market Size by Country, 2019-2027 (US$ Billion)
  • FIG. 48 United States Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 49 United States Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 50 United States Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 51 United States Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 52 United States Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 53 Canada Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 54 Canada Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 55 Canada Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 56 Canada Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 57 Canada Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 58 Rest of North America Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 59 Rest of North America Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 60 Rest of North America Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 61 Rest of North America Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 62 Rest of North America Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 63 Europe Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 64 Europe Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 65 Europe Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 66 Europe Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 67 Europe Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 68 Europe Preventive Healthcare Technologies and Services Market Size by Country, 2019-2027 (US$ Billion)
  • FIG. 69 UK Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 70 UK Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 71 UK Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 72 UK Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 73 UK Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 74 Germany Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 75 Germany Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 76 Germany Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 77 Germany Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 78 Germany Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 79 France Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 80 France Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 81 France Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 82 France Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 83 France Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 84 Spain Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 85 Spain Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 86 Spain Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 87 Spain Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 88 Spain Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 89 Italy Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 90 Italy Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 91 Italy Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 92 Italy Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 93 Italy Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 94 Rest of Europe Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 95 Rest of Europe Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 96 Rest of Europe Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 97 Rest of Europe Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 98 Rest of Europe Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 99 Asia-Pacific Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 100 Asia-Pacific Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 101 Asia-Pacific Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 102 Asia-Pacific Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 103 Asia-Pacific Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 104 Asia-Pacific Preventive Healthcare Technologies and Services Market Size by Country, 2019-2027 (US$ Billion)
  • FIG. 105 Japan Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 106 Japan Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 107 Japan Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 108 Japan Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 109 Japan Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 110 China Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 111 China Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 112 China Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 113 China Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 114 China Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 115 India Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 116 India Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 117 India Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 118 India Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 119 India Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 120 Rest of Asia Pacific Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 121 Rest of Asia Pacific Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 122 Rest of Asia Pacific Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 123 Rest of Asia Pacific Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 124 Rest of Asia Pacific Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 125 Rest of the World Preventive Healthcare Technologies and Services Market Size by Type, 2019-2027 (US$ Billion)
  • FIG. 126 Rest of the World Chronic Disease Management Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 127 Rest of the World Early Detection and Screening Technologies Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 128 Rest of the World Vaccines Market, By Type, 2019-2027 (US$ Billion)
  • FIG. 129 Rest of the World Advanced Technologies to Reduce Errors, By Type, 2019-2027 (US$ Billion)
  • FIG. 130 Rest of the World Preventive Healthcare Technologies and Services Market Size by Country, 2019-2027 (US$ Billion)
  • FIG. 131 Porter's Five forces analysis of Preventive Healthcare Technologies and Services Market
  • FIG. 132 Market Share of Key Players in Preventive Healthcare Technologies and Services Market, 2019 (%)
  • FIG. 133 Medtronic PLC, Timeline
  • FIG. 134 Medtronic PLC, Key Facts
  • FIG. 135 Medtronic PLC, SWOT Analysis
  • FIG. 136 Key Financials of Medtronic PLC
  • FIG. 137 Medtronic PLC, Revenue Split, 2019
  • FIG. 138 Alere, SWOT Analysis
  • FIG. 139 Key Financials of Alere
  • FIG. 140 Alere, Revenue Split, 2019
  • FIG. 141 GlaxoSmithKline, SWOT Analysis
  • FIG. 142 Key Financials of GlaxoSmithKline
  • FIG. 143 GlaxoSmithKline, Revenue Split, 2019
  • FIG. 144 McKesson Corporation, SWOT Analysis
  • FIG. 145 Key Financials of McKesson Corporation
  • FIG. 146 McKesson Corporation, Revenue Split, 2019
  • FIG. 147 Merck & Co., SWOT Analysis
  • FIG. 148 Key Financials of Merck & Co.
  • FIG. 149 Merck & Co., Revenue Split, 2019
  • FIG. 150 Myriad Genetics, SWOT Analysis
  • FIG. 151 Key Financials of Myriad Genetics
  • FIG. 152 Myriad Genetics, Revenue Split, 2019
  • FIG. 153 Omron Healthcare, SWOT Analysis
  • FIG. 154 Key Financials of Omron Healthcare
  • FIG. 155 Omron Healthcare, Revenue Split, 2019
  • FIG. 156 Quest Diagnostics, SWOT Analysis
  • FIG. 157 Key Financials of Quest Diagnostics
  • FIG. 158 Quest Diagnostics, Revenue Split, 2019
  • FIG. 159 Sanofi, SWOT Analysis
  • FIG. 160 Key Financials of Sanofi
  • FIG. 161 Sanofi, Revenue Split, 2019
  • FIG. 162 Tivity Health, SWOT Analysis
  • FIG. 163 Key Financials of Tivity Health
  • FIG. 164 Tivity Health, Revenue Split, 2019